Follow-On Protein Products
Author:
- A.S. RathoreARA.S. Rathore
- 1 January 2011
- book chapter
- Published by Elsevier
- p. 521-529
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Biogenerics: the hope and the hypeTrends in Biotechnology, 2009
- Regulatory aspects of biosimilars in EuropeTrends in Biotechnology, 2009
- Considerations for the development of therapeutic monoclonal antibodiesCurrent Opinion in Immunology, 2008
- Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA CouncilNephrology Dialysis Transplantation, 2008
- Immunogenicity of protein therapeuticsTrends in Immunology, 2007
- Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic proteinClinical Immunology, 2007
- A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugsNature Biotechnology, 2007
- Post-translational modifications in the context of therapeutic proteinsNature Biotechnology, 2006
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006
- Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stabilityJournal of Chromatography A, 2006